Revolutionizing Atopic Dermatitis (RAD)

home / conference / revolutionizingatopicdermatitis

RAD is where your goal to improve patients’ lives converges with meaningful discussions and groundbreaking concepts in atopic dermatitis. At this dynamic gathering, evidence drives conversations and strategies that matter are conceived, giving you an unparalleled platform to expand your skills. This year, we’re turning up the energy in Nashville. Get ready to experience Nashville’s vibrant culture and iconic music scene, right here at RAD!

Conference Highlights

Expert Interviews

Featured

Why is Early Treatment of Atopic Dermatitis So Important? Mona Shahriari, MD, Says it Could Change a Life

Mona Shahriari, MD

Jiade Yu, MD, on the Power of Multidisciplinary Collaboration in Atopic Dermatitis

Sydney Jennings

A Visible Disease with Invisible Pain: Mona Shahriari Discusses Suicide Risk in Atopic Dermatitis

Mona Shahriari, MD

Jiade Yu, MD, on the Future of Chronic Hand Eczema Treatment

Sydney Jennings

Early Atopic Dermatitis Can Be Mild, But the Threshold for Dermatology Referral Should be Low: Mona Shahriari, MD

Mona Shahriari, MD

Atopic Dermatitis in Focus: 3 Expert Pearls for Primary Care

Mona Shahriari, MD

Elizabeth Swanson, MD, FAAD

Raj Chovatiya, MD, PhD, MSCI

Sydney Jennings

Johann Gudjonsson, MD, PhD, on Emerging AD Therapies: From Single Targets to Combination Approaches

Sydney Jennings

Johann Gudjonsson, MD, PhD

When the Diagnosis is Topical Steroid Withdrawal Syndrome, a Compassionate, Collaborative History is Essential

Brad Glick, DO, MPH

Johann Gudjonsson, MD, PhD: Role of OX-40 Pathway in Atopic Dermatitis Pathogenesis

Johann Gudjonsson, MD, PhD

Sydney Jennings

On Topical Steroid Withdrawal Syndrome, We Need Bigger Studies, More Clinical Trials: Brad Glick, DO, MPH

Brad Glick, DO, MPH

The Future of Atopic Dermatitis Management: Peter Lio, MD, on Preparing for Next-Generation Treatment Strategies

Peter A Lio, MD

Sydney Jennings

Topical Steroid Withdrawal vs Atopic Dermatitis Flare: Parsing the Differences with Brad Glick, DO, MPH

Brad Glick, DO, MPH

Key Updates in Atopic Dermatitis for Primary Care

Sydney Jennings

Expanding Access to Atopic Dermatitis Treatments for Children: A Conversation with Elizabeth Swanson, MD

Sydney Jennings

Elizabeth Swanson, MD, FAAD

Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MD

Leon Kircik, MD

Why the OX-40/OX-40L Pathway Matters in Atopic Dermatitis—and What’s Next: A Q&A with Johann Gudjonsson, MD, PhD

Sydney Jennings

Johann Gudjonsson, MD, PhD

A Close Look at Flexible Dosing Strategies for Atopic Dermatitis in Adults with Raj Chovatiya, MD, PhD, MSCI

Raj Chovatiya, MD, PhD, MSCI

Pediatric Atopic Dermatitis: Navigating Patient, Provider, Caregiver Connection with Peter Lio, MD

Peter A Lio, MD

Sydney Jennings

Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD

Sydney Jennings

Flexible Dosing in in Atopic Dermatitis Treatment: Notes on Real-World Use with Raj Chovatiya, MD, PhD, MSCI

Raj Chovatiya, MD, PhD, MSCI

Understanding Chronic Hand Eczema: More Than Just Atopic Dermatitis

Sydney Jennings

Q&A: Cumulative Life Course Impairment of Atopic Dermatitis with Mona Shahriari, MD

Mona Shahriari, MD

Chronic Hand Eczema: Clinical Insights and Future Directions from RAD 2025

Sydney Jennings

Upadacitinib Shows Real-World Efficacy in Bio-Naïve, Bio-Experienced Adults with Atopic Dermatitis in New Study

Sydney Jennings

Q&A: Managing Chronic Itch With Renowned Investigator Gil Yosipovitch, MD

Gil Yosipovitch, MD

Beyond the Rash: Collaborative Insights on Pediatric Atopic Dermatitis

Sydney Jennings

Lisa Swanson, MD

Persistent Underutilization of Systemic Therapy for Atopic Dermatitis Highlights Gap Between Need and Care

Dupilumab Monotherapy Improves AD Severity and Pigmentation in People With Skin of Color

Sydney Jennings

Long-Term Data on Nemolizumab Demonstrate Safety, Sustained Symptom Improvement in Patients With Atopic Dermatitis up to 2 Years

Mona Shahriari, MD: Explore the Psychosocial Burden of Atopic Dermatitis with Your Patients—Ask Questions

Mona Shahriari, MD

Editorial Board

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.